CME vs ICE vs SPGI
161 measures in 16 categories, one definition each, computed from filings and market data.
CME56.5
CME Group Inc.
Financial Services · Financial - Data & Stock Exchanges
$293.87 +1.52%$105.7B mkt cap
Score DNA
ICE58.6
Intercontinental Exchange, Inc.
Financial Services · Financial - Data & Stock Exchanges
$161.56 +1.99%$90.7B mkt cap
Score DNA
SPGI74.4
S&P Global Inc.
Financial Services · Financial - Data & Stock Exchanges
$429.64 +1.14%$126.7B mkt cap
Score DNA
Price, rebased to 100 three years ago
CME ICE SPGI · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| Insider open-market buys, 180d | 3 | 0 | 3 |
| Insider $ bought, 180d | $0.16M | — | $2.58M |
| Congress purchases, 180d | 0 | 3 | 18 |
| Last Congress purchase | — | 2026-07-07 | 2026-08-27 |
| 13F net change in holders | −90 | −57 | −97 |
| ETFs adding shares, 30d | 1,338 | 1,303 | 1,346 |
| ETFs trimming, 30d | 1,135 | 1,144 | 1,175 |
| Net ETF funds, 30d | +203 | +159 | +171 |
Valuation
16 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| P/E (TTM) | 24.7x
56th
|
22.5x
44th
|
25.7x
67th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 1.98
78th
|
0.68
22nd
|
0.82
33rd
|
| Price / sales | 15.6x
100th
|
7.3x
40th
|
7.9x
50th
|
| Price / book | 4.0x
44th
|
3.1x
11th
|
4.0x
56th
|
| Price / tangible book | — | — | — |
| Price / free cash flow | 25.1x
80th
|
18.7x
40th
|
22.7x
50th
|
| Price / operating cash flow | 24.5x
80th
|
16.4x
30th
|
22.1x
50th
|
| Enterprise value | $106.8B
80th
|
$109.3B
90th
|
$138.3B
100th
|
| EV / sales | 15.8x
100th
|
8.8x
60th
|
8.6x
50th
|
| EV / EBITDA | 19.5x
67th
|
16.3x
33rd
|
16.8x
44th
|
| EV / EBIT | 20.5x
44th
|
21.2x
56th
|
19.7x
33rd
|
| EV / free cash flow | 25.4x
70th
|
22.5x
40th
|
24.8x
60th
|
| Earnings yield | 4.0%
50th
|
4.4%
60th
|
3.9%
40th
|
| FCF yield | 4.0%
20th
|
5.3%
60th
|
4.4%
50th
|
| Operating cash flow yield | 4.1%
20th
|
6.1%
70th
|
4.5%
50th
|
| Graham number (per share) | $139.38
88th
|
$91.42
62nd
|
$200.24
100th
|
Profitability (TTM)
12 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| Gross margin | 81.9%
90th
|
79.0%
80th
|
70.9%
50th
|
| EBITDA margin | 80.9%
100th
|
53.7%
80th
|
51.0%
70th
|
| Operating margin | 65.1%
100th
|
43.5%
60th
|
46.3%
80th
|
| EBIT margin | 76.8%
100th
|
41.3%
60th
|
43.6%
80th
|
| Net margin | 63.1%
100th
|
32.3%
60th
|
30.5%
50th
|
| NOPAT margin | 49.7%
100th
|
33.4%
60th
|
35.8%
80th
|
| FCF margin | 62.2%
100th
|
38.8%
50th
|
34.6%
40th
|
| Operating cash flow margin | 63.6%
100th
|
44.2%
60th
|
35.5%
40th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 2.1%
0th
|
25.6%
70th
|
16.9%
30th
|
| Stock comp / revenue | 1.5%
20th
|
2.1%
40th
|
1.1%
10th
|
| Effective tax rate | 23.6%
80th
|
23.4%
70th
|
22.6%
60th
|
Returns on capital
11 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| ROE (on average equity) | 15.7%
33rd
|
13.9%
11th
|
15.1%
22nd
|
| ROA | 2.3%
10th
|
2.5%
20th
|
8.0%
50th
|
| ROIC | 12.2%
50th
|
8.7%
10th
|
13.4%
60th
|
| ROCE | 14.5%
60th
|
9.6%
20th
|
13.1%
50th
|
| Return on tangible assets | 2.8%
20th
|
3.2%
30th
|
11.4%
60th
|
| Cash ROIC (OCF / invested capital) | 15.6%
40th
|
11.5%
10th
|
13.3%
30th
|
| Gross profitability (GP / assets) | 2.8%
0th
|
5.7%
10th
|
18.2%
40th
|
| ROIC, 3-yr average | 10.3%
40th
|
6.0%
10th
|
9.4%
30th
|
| ROIC, 5-yr average | 11.4%
44th
|
7.0%
0th
|
9.6%
22nd
|
| ROE, 5-yr average | 12.6%
44th
|
10.9%
22nd
|
10.6%
11th
|
| Incremental ROIC | -41.1%
50th
|
94.7%
80th
|
135.6%
90th
|
Growth
17 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| Revenue growth (TTM YoY) | 5.1%
30th
|
-0.6%
20th
|
9.7%
70th
|
| Revenue growth (QoQ) | -9.2%
20th
|
-27.3%
0th
|
-0.6%
30th
|
| Revenue CAGR, 3 yr | 8.9%
20th
|
9.2%
30th
|
10.2%
60th
|
| Revenue CAGR, 5 yr | 8.0%
40th
|
7.4%
20th
|
15.5%
90th
|
| Gross profit CAGR, 3 yr | 7.7%
30th
|
23.1%
80th
|
12.9%
50th
|
| Operating income CAGR, 3 yr | 11.7%
22nd
|
13.7%
44th
|
27.2%
89th
|
| Net income growth (TTM YoY) | 13.7%
33rd
|
34.1%
89th
|
22.7%
56th
|
| Net income CAGR, 3 yr | 12.8%
22nd
|
33.6%
78th
|
28.0%
67th
|
| EPS growth (TTM YoY) | 13.1%
22nd
|
36.2%
89th
|
27.1%
56th
|
| EPS CAGR, 3 yr | 12.5%
22nd
|
33.2%
78th
|
31.4%
67th
|
| EPS CAGR, 5 yr | 17.1%
89th
|
7.4%
22nd
|
10.3%
56th
|
| FCF growth (TTM YoY) | 2.6%
20th
|
10.8%
50th
|
3.0%
30th
|
| FCF CAGR, 3 yr | 10.7%
40th
|
15.4%
60th
|
20.5%
70th
|
| Operating cash flow CAGR, 3 yr | 10.5%
40th
|
14.9%
60th
|
20.3%
90th
|
| Book value CAGR, 3 yr | -1.8%
11th
|
7.1%
56th
|
-1.3%
22nd
|
| Dividend CAGR, 3 yr | 1.6%
12th
|
1.7%
25th
|
2.8%
62nd
|
| Sustainable growth rate | 0.7%
0th
|
10.0%
25th
|
11.6%
50th
|
Margin history & stability
7 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| Gross margin, 3-yr average | 84.7%
100th
|
63.7%
50th
|
69.6%
70th
|
| Operating margin, 3-yr average | 64.4%
100th
|
39.0%
60th
|
40.8%
70th
|
| Net margin, 3-yr average | 59.4%
100th
|
25.9%
50th
|
27.6%
60th
|
| FCF margin, 3-yr average | 62.1%
100th
|
34.9%
50th
|
35.6%
70th
|
| Revenue stability (0-1) | 0.98
60th
|
0.91
30th
|
0.99
70th
|
| Earnings stability (0-1) | 0.94
90th
|
0.13
20th
|
0.61
70th
|
| Margin stability (0-1) | 0.97
90th
|
0.82
10th
|
0.96
60th
|
Liquidity (latest quarter)
7 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| Cash & short-term investments | $2.3B
70th
|
$2.0B
60th
|
$4.1B
90th
|
| Net cash (− = net debt) | −$1.1B
80th
|
−$18.6B
0th
|
−$11.6B
10th
|
| Working capital | $2.8B
90th
|
$1.5B
80th
|
−$416.0M
20th
|
| Current ratio | 1.02
50th
|
1.01
40th
|
0.95
30th
|
| Quick ratio | 1.02
50th
|
0.04
0th
|
0.95
40th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.01
0th
|
0.02
10th
|
0.45
50th
|
| Defensive interval (days) | 972 days
90th
|
315 days
0th
|
697 days
70th
|
Leverage & solvency (latest quarter)
13 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| Total debt | $3.4B
30th
|
$20.5B
100th
|
$15.7B
90th
|
| Debt / equity | 0.13
11th
|
0.69
44th
|
0.50
22nd
|
| Net debt / equity | 0.04
22nd
|
0.63
56th
|
0.37
33rd
|
| Debt / assets | 1.8%
10th
|
11.8%
20th
|
25.0%
30th
|
| Debt / capital | 11.4%
11th
|
41.0%
44th
|
33.2%
22nd
|
| Debt / EBITDA | 0.63
11th
|
3.07
78th
|
1.91
44th
|
| Net debt / EBITDA | 0.21
11th
|
2.77
89th
|
1.41
33rd
|
| Interest coverage (EBIT / interest) | 59.3x
100th
|
6.6x
22nd
|
22.2x
89th
|
| Cash interest coverage | 49.1x
100th
|
7.1x
22nd
|
18.1x
78th
|
| Debt payback (years of OCF) | 0.8 yrs
10th
|
3.7 yrs
70th
|
2.7 yrs
50th
|
| Liabilities / assets | 86.4%
90th
|
83.0%
80th
|
41.8%
10th
|
| IS credit model rating | A+ | A | AA- |
| Implied credit spread (bps) | 125
20th
|
150
50th
|
100
10th
|
Efficiency
11 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| Asset turnover | 0.04
0th
|
0.08
10th
|
0.26
40th
|
| Fixed asset turnover | 19.28
90th
|
4.33
0th
|
24.96
100th
|
| Inventory turnover | — | 0.0 | — |
| Receivables turnover | 9.5
80th
|
7.1
50th
|
5.0
30th
|
| Days sales outstanding | 38 days
20th
|
51 days
50th
|
73 days
70th
|
| Days inventory outstanding | — | — | — |
| Days payables outstanding | 24 days
30th
|
155 days
100th
|
44 days
70th
|
| Cash conversion cycle (days) | 14 days
56th
|
— | 28 days
89th
|
| Capex / revenue | 1.4%
44th
|
5.3%
78th
|
1.0%
33rd
|
| Capex / depreciation | 0.35
44th
|
0.43
56th
|
0.13
22nd
|
| Operating expense ratio | 4.4%
0th
|
47.8%
90th
|
21.1%
10th
|
Cash flow & earnings quality
7 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| Operating cash flow / net income | 1.01
11th
|
1.37
78th
|
1.16
33rd
|
| FCF / net income | 0.99
22nd
|
1.20
78th
|
1.13
44th
|
| FCF / operating cash flow | 97.8%
67th
|
87.9%
44th
|
97.3%
56th
|
| Capex / operating cash flow | 2.2%
33rd
|
12.1%
56th
|
2.7%
44th
|
| Accruals ratio | -0.0%
90th
|
-0.9%
80th
|
-1.3%
60th
|
| Sloan accruals ratio | -0.0%
90th
|
-0.4%
80th
|
-2.5%
70th
|
| Earnings quality score (0-1) | 1.00
33rd
|
1.00
33rd
|
1.00
33rd
|
Scores & forensic checks
15 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| IS score | 56
10th
|
59
20th
|
74
90th
|
| IS profitability | 75
50th
|
74
20th
|
80
90th
|
| IS growth | 53
40th
|
56
50th
|
63
70th
|
| IS value | 56
60th
|
58
80th
|
52
40th
|
| IS momentum | 74
30th
|
85
60th
|
87
80th
|
| IS risk (safety) | 65
0th
|
100
10th
|
100
10th
|
| IS quality | 80
70th
|
85
100th
|
84
90th
|
| IS balance sheet | 60
80th
|
42
10th
|
62
90th
|
| IS earnings quality | 82
80th
|
83
90th
|
74
40th
|
| IS cash flow | 83
90th
|
78
70th
|
75
30th
|
| Piotroski F-score (0-9) | 6
30th
|
8
80th
|
7
50th
|
| Altman Z-score | — | — | — |
| Beneish M-score | — | — | — |
| Ohlson O-score | −6.77
80th
|
−6.99
70th
|
−9.47
0th
|
| IS credit score | 80
80th
|
74
50th
|
80
90th
|
Size (TTM)
8 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| Market cap | $105.7B
90th
|
$90.7B
80th
|
$126.7B
100th
|
| Revenue | $6.8B
60th
|
$12.5B
90th
|
$16.1B
100th
|
| EBITDA | $5.5B
80th
|
$6.7B
90th
|
$8.2B
100th
|
| Net income | $4.3B
90th
|
$4.0B
80th
|
$4.9B
100th
|
| Free cash flow | $4.2B
80th
|
$4.8B
90th
|
$5.6B
100th
|
| Total assets | $194.7B
100th
|
$174.2B
90th
|
$62.9B
80th
|
| Shareholders' equity | $26.5B
80th
|
$29.6B
90th
|
$31.6B
100th
|
| Employees | 3,875
10th
|
12,725
70th
|
44,500
100th
|
Price performance
9 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| 1 day | +1.5% | +2.0% | +1.1% |
| 1 week | +4.7% | +3.4% | +5.3% |
| 1 month | +8.4% | +5.4% | +6.3% |
| 3 months | +19.9% | +14.1% | −4.2% |
| 6 months | +2.2% | +0.2% | −2.9% |
| Year to date | +9.0% | +1.0% | −16.0% |
| 1 year | +10.1% | +2.9% | −10.8% |
| 3 years, cumulative | +48.8% | +49.0% | +17.5% |
| 5 years, cumulative | +74.0% | +33.3% | +3.6% |
Technicals
4 measures| Measure | CME | ICE | SPGI |
|---|---|---|---|
| RSI 14 | 71.4 | 64.0 | 65.4 |
| From 52-week high | −8.6% | −8.2% | −22.0% |
| From 52-week low | +34.6% | +32.7% | +15.6% |
| Beta | 0.27 | 0.94 | 1.09 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17